ProfileGDS4177 / 238076_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 78% 77% 88% 85% 73% 67% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated179.2378
GSM603099KU-812 non-treated171.4977
GSM603098KCL-22 Imatinib-treated437.3188
GSM603097KCL-22 non-treated346.4685
GSM603102JURL-MK1 Imatinib-treated118.6873
GSM603101JURL-MK1 non-treated77.5467